Search

everythinglearnresearchcommunity

for

Search:↓

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

Early hormones shape sex-specific differences in rat glands.

Women with PCOS have a higher risk of heart disease.

Balanced hormones are crucial for women's health, and can be managed with lifestyle changes or hormone therapy if needed.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Nanotechnology improves Clomiphene citrate's effectiveness and reduces side effects for treating ovulatory disorders.

Hormonal changes and conditions like polycystic ovarian syndrome are major causes of adult acne in women, with varying prevalence among different ethnicities.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Reference values for nine hormones were established to help diagnose PCOS.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

GnRH treatment can reduce breast cancer cell invasion.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

Metformin can start ovulation and may lower 17P response in PCOS, but six months is too short to improve hair growth or change body fat distribution.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.